# Lenvatinib as a therapy for unresectable hepatocellular carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lenvatinib-as-a-therapy-for-unresectable-hepatocellular-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrea Spallanzani,Giulia Orsi,Kalliopi Andrikou,Fabio Gelsomino,Margherita Rimini,Laura Riggi,Stefano Cascinu |
| Citations | 39 |
| DOI | 10.1080/14737140.2018.1524297 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2891260437 |
| PMID | 30220234 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Giulia Orsi](https://scholariq.org/researchers/giulia-orsi/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.